-

William Blair Names John Kreger Director of Research

CHICAGO--(BUSINESS WIRE)--William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, announced today that John Kreger has been named director of research of the firm’s sell-side equity research group. Based in Chicago, Kreger will oversee a team of research analysts responsible for coverage of more than 700 growth-oriented companies.

“I am thrilled to announce John’s new role as director of research for William Blair, serving as a capstone to a sterling 23-year career as a research analyst for the firm,” said Scott McLaughlin, head of equities at William Blair. “John is highly respected inside William Blair and externally by the global investment community. He is the perfect leader for our award-winning equity research group.”

Kreger draws on nearly 30 years of experience in equity research. He has been a partner at William Blair since 2003, and throughout his career has covered growth companies in healthcare services subsectors including pharmaceutical outsourcing, dental, and animal health, among others. Before joining William Blair, Kreger served as a research analyst at Vector Securities International, also covering companies in the healthcare industry. Kreger received his M.B.A. from the University of Chicago and his B.B.A. from the University of Michigan.

“It is an honor to be named director of research for William Blair, and I am humbled by the opportunity to lead a team of analysts who work tirelessly to deliver superior investment ideas and value-added perspective for hundreds of companies across myriad sectors,” Kreger said. “Under Scott’s leadership of William Blair’s institutional sales, trading, and research group, we are poised to further elevate the team’s performance and expose the industry to the strength and depth of this wonderful team.”

In 2022, William Blair earned seven No. 1 rankings from Coalition Greenwich’s annual survey of North American equity investors, which was conducted with 94 small- and midcap fund managers and 241 U.S. buy-side trading desks that use electronic trading.

William Blair’s award-winning equity research group provides investment perspective on companies from six primary sectors: consumer; financial services and technology; global industrial infrastructure; global services; healthcare; and technology, media, and communications. Companies under coverage represent a diverse geographic footprint and range across the market-capitalization spectrum, with an emphasis on small- and midcap stocks. The group uses multiple factors to identify high-quality companies with attractive growth prospects.

About William Blair

William Blair is the premier global boutique with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 20 offices worldwide.*

*Includes strategic partnerships with Allier Capital, BDA Partners, and Poalim Capital Markets.

Contacts

William Blair


Release Summary
William Blair Names John Kreger Director of Research of the Firm's Sell-Side Equity Research Group
Release Versions

Contacts

More News From William Blair

William Blair Investment Management Launches Global Leaders Select Strategy, Appoints Chandan Khanna as Co-Portfolio Manager

LONDON--(BUSINESS WIRE)--William Blair Investment Management today announced the launch of the Global Leaders Select Strategy, with the appointment of Chandan Khanna as Co-Portfolio Manager alongside Hugo Scott-Gall, Head of William Blair’s Global Equity Team. The Global Leaders Select strategy is a concentrated portfolio of 25-35 leading global companies which combine quality and growth characteristics. The strategy is benchmark-agnostic and aims to deliver strong long-term returns for investo...

William Blair Hires Head of Biopharma Investment Banking, based in New York

NEW YORK--(BUSINESS WIRE)--William Blair announced today the expansion of the firm’s Healthcare team with the addition of Michael Allwin as managing director and head of Biopharma investment banking. Based in New York, Allwin will lead the firm’s global efforts to provide comprehensive advisory services to public and private biopharma companies across all stages of development as well as financial sponsors and venture firms focused on the sector. “Michael will play a critical role in further ex...

William Blair Investment Management Appoints Olga Bitel as Chief Investment Strategist

CHICAGO--(BUSINESS WIRE)--William Blair Investment Management announced today the appointment of Olga Bitel as Chief Investment Strategist. In this newly established role, Bitel will help shape William Blair Investment Management’s investment perspective across global markets and economies, drawing on the firm’s broad investment expertise to provide investors with insight into the forces influencing portfolio outcomes and long-term investment opportunities.As Chief Investment Strategist, Olga wi...
Back to Newsroom